Dr. Nivedh Venkat Paluvoi, MD

Dr. Paluvoi practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Paluvoi's NPI, 1043575194, was assigned on July 4, 2012. Dr. Paluvoi graduated from Howard University College Of Medicine in 2012. Dr. Paluvoi holds Florida license ME137048.

Dr. Paluvoi's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Paluvoi's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Paluvoi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paluvoi practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Paluvoi's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Paluvoi is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Paluvoi's licenses on file in 3 states: Florida, California and Massachusetts.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Paluvoi treats.

CMS data shows 74 Medicare services from Dr. Paluvoi across 3 procedure codes in 2024, for 96 Medicare patients. Medicare paid $4,474 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 96 Medicare patients who saw Dr. Paluvoi in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Paluvoi's median patient age at 66, with 51% women.

In 2024, Dr. Paluvoi wrote 104 Medicare Part D claims for 52 patients. 90% of them were for generic drugs. CMS names the drug for 34 of them, across 2 drugs with 11 or more claims each, at $376 in total drug cost. In 2023, CMS named 49 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Paluvoi for performance year 2024, reported as part of a group. Dr. Paluvoi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Paluvoi as offering telehealth. CMS counts 37 procedures of colonoscopy by Dr. Paluvoi, more than 57% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Dr. Paluvoi, published from 2012 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Cecum, Postoperative Complications and Rectal Neoplasms. Dr. Paluvoi has published most often in Am Surg. Dr. Paluvoi's most frequent co-authors are Karishma Kodia, MD, Bhuwan Giri, MD and Sara Danker, MD.

CMS Open Payments shows 72 general payments to Dr. Paluvoi from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Guard Medical Inc. paid the most, $15,399.

Dr. Paluvoi graduated from Howard University College Of Medicine in 2012. Dr. Paluvoi is a member of ACS and ASCRS.

Dr. Paluvoi is in network with 9 carriers, including Aetna, United Healthcare and Molina. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.